Philip J. Johnson
About Philip J. Johnson
Company Affiliation at Nuvaira
Philip Johnson, Ph.D., is Vice President of Science, Clinical, and R&D at Nuvaira. He has been part of the company since 2013. Nuvaira is involved in developing and commercializing innovative therapies to address chronic obstructive pulmonary disease (COPD). Johnson's role encompasses oversight of scientific research, clinical operations, and research and development initiatives within the company.
Education and Credentials
Philip Johnson holds a B.S. in Biomedical Engineering from Saint Louis University. He furthered his expertise by obtaining both a M.S. in Biomedical Engineering and a Doctor of Philosophy degree in Biomedical Engineering from Washington University in St. Louis. His comprehensive education has equipped him with specialized knowledge in biomedical engineering, focusing on areas such as peripheral nerve injuries and nerve regeneration.
Biomedical Research Experience
Philip Johnson has accumulated 15 years of experience in biomedical research. His areas of expertise are peripheral nerve injury, autonomic innervation of the lung, and neuromodulation therapies. He has contributed significantly to these fields through research and development, working on improving outcomes following traumatic nerve injuries and exploring new therapies.
Academic and Research Background
Before joining Nuvaira, Philip Johnson served as the Director of the Peripheral Nerve Research Laboratory and an Assistant Professor of Surgery at Washington University School of Medicine. During his tenure, he managed an NIH-funded research laboratory that focused on the basic science of peripheral nerve injury and regeneration. He worked on developing tissue engineering techniques to enhance the recovery process following traumatic nerve injuries.
Publications and Contributions
Philip Johnson has published over 35 peer-reviewed manuscripts focusing on peripheral nerve injury and tissue engineering. His research contributions have been pivotal in advancing the understanding and treatment of nerve injuries, enabling further improvements in biomedical practices and therapies. His published works are esteemed in the biomedical engineering community for their depth and impact.